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Summary: This article describes the Synthesis of labelfc and hapten-protein conjugates for use in bio- and
chemiluminescent immunoassay Systems, together witn the problems encountered.
The effects of maleimide upon acetate-, adenylate- and pyruvate kinase activity have been studied, äs well äs
upon the luciferin-luciferase monitoring System. Maleimide inhibited both acetate and adenylate kinase but
showed no Inhibition of pyruvate kinase and the monitoring reagent.
Fouf heterobifunctional reagents were tested for their capability in forming pyruvate kinase-donkey-anti-rab-
bit IgG conjugates which retained enzyme and antibody activity. The best results were obtained with succin-
imidyl-4-(N-maleimidomethyl)-cyclohexane-l-carboxylate and sucdnimidyl-6-(p-maleimidophenyl)-hexa-
noate.
The relationship between the amounts of succinimidyl-4-(N-maleimidomethyl)-cyclohexane-l-carboxylate
and IgG was studied with respect to enzymic activity of the conjugate.
The Michaelis-Menten constants for both conjugated and non-conjugated pyruvate kinase were calculated and
compared. It was found that the maximal velocity (Vmax) of the conjugated enzyme was lower than that of the
non-conjugated enzyme although the "apparent" Km value was the same for both conjugated and non-conju-
gated pyruvate kinase.
The pyruvate kinase-anti rabbit IgG conjugate was tested for its ability to bind to rabbit-IgG coated polysty-
rene balls.
In addition to bioluininescent labels, the synthesis of chemiluminescent markers was undertaken and opti-
mised. The three substances used for labelling were diazoluminol, diazoisoluminol and N-(4-aminobutyl)-N-
ethylisolumiiiol hemisuccinamide the latter being used äs an N-hydroxysuccinamide "active" ester.
The-ratio of label to IgG was studied ior diazoluminol and N-(4-aminobutyl)-N-ethylisoluminol hemisuccin-
amide active ester after it had been discovered that diazoisoluminol was not suitable for coupling to antibo-
dies. The optimal molar ratios label: IgG were for diazoluminol 40:1 and for N-(4-aminobutyl)-N-ethylisolu-
minol hemisuccinamide active ester 60:1. Increasing the Substitution rate led to a lessening of the dynamic
ränge, shown by an increase in the ratio between utispecific binding (noise) to maximal binding (signal) in an
assay.
The synthesis of hapten-protein conjugates for covalent coupling to polystyrene balls was undertaken äs this
formed part of the preparation for the assays described in Part III. The optimal production of gentamicin-bo-
vine serum albumin and thyroxine-transferrin conjugates has been described in de tau.
0 Part 1: J. Clin. Chem. Clin. Biochem. 27, 789-797. Part III: J. Clin. Chem. Clin. Biochem. 22, 349-356.
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Synthese und Beurteilung von Lumineszenz-Markern und Haplen-Protein-Konjugaten für Lumineszenz-Im-
munoassays mit immobilisierten Antikörpern und Antigenen.
Eine kritische Untersuchung von Makro-Festphasen zum Gebrauch in Immunoassay* Systemen, Teil 7/1)
Zusammenfassung: Dieser Beitrag beschreibt die Herstellung von Markern für die Verwendung in Bib- und
Chemilumineszenz-Immunoassays und zeigt die dabei bestehenden Probleme auf. · \
Der Effekt von Maleinimid auf Acetat-, Pyruvat- und Adenylat(Myo)kinase zur Klärung ihrer Verwendbar-
keit als Biolumineszenzmarker wurde untersucht. Lediglich bei der Pyrüvatkinase wurde keine Hemmung
beobachtet, das Luciferin-Luciferase-System (Indikator-Reagenz) blieb ebenfalls unbeeinflußt.
Vier heterobifunktionelle Reagenzien wurden auf ihre Eignung für die Synthese von Esel-anti-Kaninchen
IgG-Pyruvatkinase-Konjugaten untersucht. Die besten Konjugate wurden mit Succinimidyl^-iN-maleimi-
domethyl)-cyclohexan-l-carboxylat und Succinimidyl-6-(p-maleimidophenyl)-hexanoat erzielt.
Das molare Verhältnis von Succinimidyl-4-(N-maleimidomethyl)-cyclohexan-l-carboxylat zu IgG wurde im
Hinblick auf die Beeinflussung der enzymatischen Aktivität ihres Konjügates mit Pyrüvatkinase untersucht.
Die Michaelis-Menten Konstanten für konjugierte sowie unkonjugierte Pyruvatkinase wurden bestimmt und
gegenübergestellt. Dabei konnte eine Abnahme der maximalen Reaktionsgeschwindigkeit des an IgG gekop-
pelten Enzyms nachgewiesen werden. Es ergab sich dabei ein „apparenter" /Cm-Wert, der dem ungebundener
Pyruvatkinase entsprach.
Die Bindungsfähigkeit der Pyruvatkinase-Esel-anti-Kaninchen-IgG^Komplexe an mit Kaninchen-IgG be-
schichtete Polystyrolkugeln wurde untersucht und dokumentiert.
Darüberhinaus wurde die Synthese von Chemilumineszenz-Konjugaten untersucht und optimiert. Die Eig-
nung von Diazoluminol, Diazoisoluminol sowie N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamid (akti-
ver Ester) zur Kopplung an IgG wurde untersucht und die optimalen Verhältnisse zu IgG erarbeitet. Diese
betragen für Diazoluminol zu IgG etwa 40:1 und für N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamid
(aktiver Ester) zu IgG etwa 60:1. Diazoisoluminol war nicht zur Kopplung an IgG verwendbar. Höhere
Substitutionsraten führten für Diazoluminol zu einem Anstieg der unspezifischen Bindung bei gleichzeitiger
Erniedrigung der spezifischen Bindung. Im Falle von N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamid
(aktiver Ester) veränderte sich das Verhältnis von unspezifischer zu spezifischer Bindung trotz höherer Sub-
stitution nur unwesentlich.
Die Synthese von Hapten-Protein-Konjugaten zur kovalenten Kopplung an Polystyrölkügeln wurde durchge-
führt, da sie Teil der Vorbereitung für die in Teil III beschriebenen Assays ist. Die optimierte Herstellung von
Gentamycin-Rinderserumalbumin- und Thyroxin-Transferrin-Konjugaten ist im Detail beschrieben.
Introduction
There are two distinct types of label used in lumines-
cence immonoassays, which are usually referred to
äs chemiluminescent and bioluminescent marker
substances. The difference äs far äs the assay tech-
nique itself is concerned, is only in the way in which
the light is produced at the end of all reaction Steps.
Labels commonly used in bioluminescence immu-
noassays are kinases (l, 2, 3) and NAD(P)-depend-
ent dehydrogenases (4, 5).
Difficulties arise in stabilising bioluminescent labels
in liquid form however, äs the enzymes present are
inhibited by conventional antimicrobial agents such
äs azide or merthiolate.
Chemiluminescent labels include derivatives of iso-
luminol (6, 7, 8), acridinium esters (9), azoluminol
(10) and fluorescein isothiocyanate (11).
Useful labels examined in this study are pyruvate ki-
nase (EC 2.7.1.40) äs bioluminescence-(1^3), dia-
zpluminol (10) and N-(4-aminobutyl)-N-ethylisolu-
minol hemisuccinamide active ester äs chemilumi-
nescence labels.
The bioluminescent System is based ori" an ATP-geri-
erating System coupled to a firefly lüciferin=4ucife-
fase light generating reaction (1—3). A species-spe-
cific antibody is labelled, which results in the forma-
tion of a pyruvate kmase-immunbglobulin G conju-
gate.
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Coupling reactions have been tested using different
heterobifunctional reagents (l, 12) having a maleim-
ide and N-hydroxysuccinimide functional group for
coupling via thiol and aminogroups respectively.
This type of reagent is far superior to alternative rea-
gents such äs pentane-l,5-dial, carbodiimides or
mixed anhydride reactions. The reaction is a two-
step one, the first being the aminoacylation of the
IgG followed by the formation of a thioether with
the pyruvate kinase.
The optimisation of Signal to noise ratio in terms of
the maximum and unspecific binding has been stu-
died in terms of reagent and reactant purity and de-
gree of Substitution of the label.
The somewhat complicated synthesis of N-(4-ami-
nobutyl)-N-ethylisoluminol hemisuccinamide active
ester (8) described in the literature was replaced by a
simpler method which could be performed in almost
any laboratory.
Tab. l. Reactions catalysed by the kinases used in this study. All
, reactions were "driven" in the direction of ATP forma-
tion.
1. Pyruvate kinase - EC 2.7. l.40 (from rabbit muscle)
Phosphoenolpyruvate + ADP = Pyruvate + ATP
Cofactors Mg+2 and K+
pH Optimum — 7.0
2. Acetate kinase - EC 2.7.2.1 (from E. Coli)
Acetyl phosphate -H ADP = Acetate + ATP
Cofactors probably Mg"1"2 or Mn+2
pH Optimum — 7.4
3. Adenylate kinase - EC 2.7.4.3 (from rabbit muscle)
2 ADP = ATP + AMP
Cofactor Mg*2
pH Optimum — 6.7
Explanations:
Adenylate kinase is also known äs myokinase.
All reactions could be run in the reverse direction äs only an ex-
change of high energy phosphate bonds took place.
Materials and Methods
Materials
Unless otherwise stated, materials were obtained from the same
sources äs in the first part of this publication (14). Pyruvate ki-
nase, acetate kinase and adenylate kinase (myokinase) were pur-
chased from Boehringer-Mannheim, Mannheim, D.
All heterobifunctional reagents were obtained from Sigma, Mu-
nich, D, except for the n-hexanoyl derivative, which was a gift
from Boehringer-Mannheim.
ATP-monitpring kits arid N-(4-aminobutyl)-N-ethyIisoluminol
hemisuccinamide were bought from LKB, Munich, äs were the
gels Ultrogel A4 and A6.
Glutathione (reduced form), 5,5/-dithiobis(2-nitrobenzoic acid),
adenosine diphosphate (ADP) and phosphoenolpyruvate were
obtained from Sigma, Munich.
Buffer sübstances were purchased from Merck, Darmstadt, D.,
and from EGA-Chemie, (Aldrich) Steinbach, D.
Methods
Effects of maleimide upon monitoring reagent and pyruvate-, ace-
tate- and adenylate kinase activity
All enzyme reactions were run in the "reverse" direction, synthes-
ising adenosine triphosphate (ATP) from the relevant compo-
nents. The enzyme reactions are shown in Table 1.
First the effect of maleimide upon the ATP-monitoring reagent
was studied, to check for Inhibition of light production in the luci-
ferin-luciferase System.
Increasing amounts of maleimide (covering the ränge 0.1—125
mmol/tübe) were added to suitable dilutions öf the enzymes in
incubatiön buffer (0.05 raol/1 Tns-HCl containing 2.5 g/l bovine
serum albiimin and 0.1 mol/1 KC1 adjusted to pH 7.4), the effects
on the rate of ATP synthesis being plotted against time. ATP pro-
duction was measured kinetically using an ATP-monitoring kit
and an LKB 1250 Luminometer with printer display (see section
"Studies upon the effect . . ." for detailed Information).
Synthesis of the pyruvate kinase IgC conjugates
The -globulin fraction of a donkey anti-rabbit IgG serum (Well-
come RD 17) was prepared using polyethylene glycol precipita-
tion followed by DEAE-cellulose column chromatography, (2,
15). The IgG concentration was around 15 g/l in the eluate.
To a solution of IgG (15 g/l) containing a total of 15 mg dissolved
in l ml buffer 2 (0.02 mol/1 potassium phosphate containing 0.15
mol/ NaCl, adjusted to pH 7) was added l ml of the respective
heterobifunctional reagent (for structure of these reagents see
fig. 1.) representing l umol^-lO (see section "Studies upon
the e f f e c t . . . " below). The mixture was incubated for 45 min at
ambient temperature and then dialysed twice for l h against 11
buffer 2. The degree of coupling was determined by the titration
of the free thiol groups on the IgG-heterobifunctional reagent
complex with Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic
acid)) in which 2-nitro-5-mercaptobenzoic acid is produced in the
presence of free —SH groups. The latter gives an intensive yellow
coloufed anion which can be measured photometrically at 412 nm
(16,17). A Standard curve was set up using reduced glutathione äs
calibratpr covering the ränge 0—50 nmol/tube.
In order to obtain a label with a higher molar ratio pyruvate ki-
nase: IgG, the pyruvate kinase concentration was held at 4 times
that of IgG.
The reaction was allowed to proceed for 25 min at room tempera-
ture and was stopped by addition of 100 nmol reduced glutathi-
one. The mixture was then separated on an Ultrogel A6 column
(100 x 1.8 cm) using buffer 2 äs eluent. The antibody binding
potency and enzyme activity were tested in each fraction, the op-
timal fractions showing both enzyme activity and specific antibody
binding pooled, portioned and lyophilised after addition of l mg
lactose to each portion. The pyruvate kinase activity was tested
for äs already described (1), the antibody binding potency by
binding studies using rabbit IgG covalently coupled to polystyrene
balls (14).
Studies upon the effect of heterobifunctional reagent concentration
with respect to enzyme activity
The effect upon enzyme activity after coupling to IgG was studied
using three different concentrations of succinimidyl-4-(N-malc-
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CH2-B
A-(CH2)5-
ΙΠ
Fig. 1. The structure of the four heterobifunctional reagents used
in this study:
I m-maleimidobenzoyl N-hydroxysuccinimide ester
II succinimidyl-4-(N-maleimidomethyl)-cyclohexane-l-
carboxylate
III succinimidyl-6-(p-maleimidophenyl)-hexanoate
IV suc nimidyI-4-(p-maleimidophenyI)-butyrate
The structures A (N-hydroxysuccinimide-ester group) and
B (maleimide group) shown in the lower portion of the
diagram are the two functional groups common to the rea-
gents represented here.
The same System was used to calculate the Km value for phospho-
enolpyruvate. Here the ADP concentration was kept constant at
6 g/l, the concentrations for phosphoenolpyruvate were varied s
described above for ADP. The Km value for "free" pyruvate ki-
nase was measured using a 10 μΐ aliquot, equivalent to l ng/tube.
Lineweaver-Burk plots were made in order to derive the Km-
values for ADP and phosphoenolpyruvate/
Diaiotisation of luminol and isoluminol
On account of conflicting reports in the litefature (10) and per-
sonal expef ience, the effects of diazotisation time, pH and Substi-
tution rate into IgG have been studied. Binding studies have been
carried out using the relevant IgG against which the labelled anti-
body is directed, coupled to polystyrene balls (14).
Luminol or isoluminol (l mmol) was suspended in 5 ml l mol/1
HCI and cooled under constant stirring to 0 °C (ice bath). KNO^
(1.5 mmol) was dissolved in l ml distilled water and cooled in ice.
The cold KNO2 solution was added dropwise to the luminol/isolu-
minol Suspension respectively, until the green-yellow slurry be-
came a clear orange (luminol) or yellow-orange (isoluminol) solu-
tion. The time taken for the addition of nitrite was 15—20 min.
An excess of HNO? is usually undesirable if the diazotised reacr
tant is to be used straight away because of further unwanted dia-
zotisation of the second reactant, here IgG. In this case, s IgG
molecules contain no arylamino groups, no such side reactions
should occur. However, the presence of excess nitrite ions were
tested for using starch iodide paper, a blue^black coloration de-
noting the presence of nitrite. This was removed by adding a few
drops of urea solution (l mol/1) until the reaction with starch-io-
dide paper was negative. The diazoluminol or diazoisoluminol was
•used immediately for the preparation of labels. The diazo con>
pounds were stable for periods up to 7 days at —20 °C, but even
during this time, their effectiveness s coupling reagents deterio-
rated. A quick test to see if the diazoluminol was still useable was
that if, after addition of a drop of K2CO3 (l mol/1) the red c lora^
tion was stable for more than 30 minutes it could still be used for
coupling. In the case of diazoisoluminol, the yellow orange solu-
tion turned golden yellow and crystallised out inside 30 minutes
after beeing synthesised. The resulting Suspension was used for
conjugation to IgG. ^ ?-· *
imidomethyl)-cyclohexane-l-carboxylate, with a molar ratio IgG:
succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1 -carboxylate
of 1:1.2, 1:6 and and 1:10.
Conjugates were made s in section above, but with additional
purification after the succinimidyl-4-(N-maleimidomethyl)-cyclo-
hexane-1-carboxylate-IgG coupling using a Sephadex G-25 co-
lumn (30 x 1.5 cm). Pyruvate kinase was allowed to react in a
four-fold excess, and the optimal fractions (see above) used to
calculate the Michaelis-Menten constant. The necessary experi-
ments were carried out s set out below:
100 μΐ of a 1:600 dilution of the conjugate (ca. 2.8 pg IgG) were
reacted with a rabbit IgG-coated polystyrene ball (14) in 200 ul
incubation buffer for 3 h at ambient temperature (23 °C). The
polystyrene ball was then washed with incubation buffer (2 x 500
ul) and 0.15 mol/1 NaCl (l x 500 ul).
The measurement of ATP production in order to calculate the
Km-value for ADP was carried out using the following System:
200 μΐ Tris-HCl buffer (0.1 mol/1, pH 7.4)
100 μΐ ATP monitoring reagent
50 μΐ Phosphoenolpyruvate (2 g/l in 0.2 mol/1 KCl/MgSO4)
50 μΐ ADP (end concentration/tube 4, 0.8, 0.4, 0.08, 0.04 and
0,008 μιηοΐ)
Preparation of diazoluminol· and diazoisoluminol·antibody con-
jugates
These experiments were carried out to check the effect of pH,
time and the ratio of coupling reagent to IgG oh the q ality of the
products formed.
The diazoluminol or diazoisoluminol preparation was added slow-
ly to l ml of the IgG solution (15 g/l) in buffef 2 under constant
stirring in an ice bath to give final ratios of diazoluminol/diazoiscn
luminohlgG of 20:1. The re ction times were 6, 24 and 72 h at
pH 4 and pH 9 at 4°C. Potassium carbonate solution (l mol/1)
was added dropwise to maintain the pH between 9.0 and 9.2. The
reactions at pH 4 were carried out maintaining the pH with 0.5
mol/1 potassium phosphate buffer pH 7.
After the addition of diazotised (iso)Iuminol, the reaction was al-
lowed to proceed at 4 °C during which time the reaction mixture
changed from red to yellow in case of pH 9 derivatives, those at
pH 4 remaining pale yellow throughout the coupling procedure.
After the reaction all reation mixtures were purified over an Ul-
trogel A4 column (30 x 2.5 cm) with buffer 2 s eluent, collecting
30 drop fractions (1.5 ml). The coloured fractions were tested for
specific and unspecific binding to IgG and transferrin coated poly-
styrene balls respectively (14).
To check the effect of changing the ratio lurninogen: IgG diazolu-
minol was used at pH 9 with a 24 h reaction time at 4 °C s these
conditions were optimal.
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The ratio of diazoluminol: IgG was varied between 8: l and 200: l.
Separation of the reaction componenls was made with an Ultrogel
A4 (see above).
From the resulting data it was estimated that an effective (immu-
noreactive) Substitution of 23-28 gentamicin per bovine serum
albumin had taken placc.
Optitnised preparation of N- (4-aminobutyl) -N-ethylisoluminol he-
misuccinamide active ester
18.5 mg (50 μιηοΐ) N-(4-aminobutyl)-N-ethyIisoIuminol hcmisuc-
cinamide wcre dissolved in 800 μΐ dry dimethylformamide under
slight warming. N-Hydroxysuccinimide (5.75 mg = 50 μπιοί) was
added at room temperature, the mixture being stirred. When the
N-hydroxysuccinimide had been dissolved, 30.9 mg (150 μηηοΐ)
dicyclohexylcarbodiimide dissolved in 200 μΐ dry dimethylfor-
mamide were added. After 20 h at room temperature without stir-
ring and under light exclusion (aluminium foil covered reaction
vessel) the mixture was used for direct coupling to antibodies and
antigens. During the reaction, crystals of dicyclohexyl urca precip-
itated out.
A low temperature of about 4 °C slows down the formation of the
active ester and an increase in incubation time at room tempera-
ture (>20 h) gave no increase in N-(4-aminobutyl)-N-ethylisolu-
minol hemisuccinamide active ester formation.
Product formation was confirmed using thin layer Chromato-
graphie techniques. The solvent used was ethyl acetate ethanol
NH3 (25 g/l) 5 + 2 + l (by volume). The Rf-values obtained were
s follows: N-(4-aminobutyl)-N-ethylisoluminol hemisuccinam-
ide - 0.074, N-hydroxysuccinimide - 0.14, N-(4-aminobutyl)-N-
ethylisoluminol hemisuccinamide active ester — 0.4. Some other
spots were observed which demonstrated neither fluorescence
when excitated at 366 nm nor luminescence when excited with
alkaline microperoxidase and H2Oz.
Preparation of N-(4-aminobutyl)-N-ethylisoluminol hemisuccin-
amide active ester-antibody conjugates
The γ-globulin fraction of a donkey anti-rabbit IgG serum was
prepared s described in Section Synthesis . . .". To 3 x 2 ml
(30 mg protein) portions of this preparation different amounts of
the N-(4-aminobutyl)-N-ethylisoIuminol hemisuccinamide active
ester preparation were added to give final ratios N-(4-aminob -
tyl)-N-ethylisoluminol hemisuccinamide active ester: IgG of 30:1,
60:1 and 120:1 respectively. After the addition, a precipitate of
water insoluble components formed immediately. The reaction
was allowed to continue for 24 h at 4 °C under light exclusion.
After centrifugation (10 min at 4000 min""1) the supernatant was
transferred to an Ultrogel A4 (30 x 2.5 cm) column using 0.05
mol/1 tris/HCl pH 8 s eluent, collecting fractions of 1.5ml.
The test System for specific and unspecific binding was identical
with that described in the preparation of diazoluminol and diazo-
isoluminol-IgG.
Synthesis of a gentamicin-bovine serum albumin conjugate for the
gentamicin SPALT assay (see tab. 2)
The coupling reagefit used was l-cyclohexyl-3-(2-mofpholinyl-
(4)-ietllyl)-carbodiimide methyl-p-toluene sulphonate (MCDI).
The molar ratios ch sen were: bovine serum albumin: carbodiim-
ide (MCDI): gentamicin — 1:60:80. Bovine serum albumin
(68 mg) and 48 mg gentamicin were dissolved in 4 ml distilled wa-
ter and the pH adjusted to 4.5 with dropwise addition of 0.1 mol/1
HC1. Carbodiimide (MCDI, 28 mg) were dissolved in 500 μΐ dis-
tilled water and added dropwise to the bovine serum albumin-
gentamicin mixture. The pH of the resulting mixture was held
constant at 4.5 with 0.1 mol/1 HC1 for the next hour after which
the reaction was ailowed to proceed at 4°C overnight.
Seperation of complex and unreacted gentamicin was effected via
an Ultrogel A6 column (30 x 2.5 em) using buffer 2 s elution
buffer. The column fractions were tested for protein conterit
) and gentamicin immunoreactivity (radioimmunoassay).
Synthesis of a thyroxine-transferrin conjugate for a 7VSPALTas-
say
This conjugate was synthesized for the T4-SPALT assay in part III
of this trilogy and is described here s it is part of the preparation
for an assay.
The coupling reagents ch sen were l-cyclohexyl-3-(2-morpholin-
yl-(4)-ethyl)-carbodiimide methyl-p-toluene sulphonate (see
above) or l-ethyl-3-(3-dimethyl aminopropyl)carbodiimide hy-
drochloride (EDAC).
The molar ratios ch sen were:
Transferrin:carbodiimide(EDAC):thyroxine - 1:50:200.
44 mg transferrin were dissolved in 500 μΐ distilled water and the
pH adjusted to 6 using 0.1 mol/1 HC1. 20 mg thyroxine were sus-
pended in l ml distilled water and brought into solution by drop-
wise addition of 0.5 mol/1 NaOH. The carbodiimide solution was
added dropwise to the transferrin solution keeping the pH at 6,
the mixture bcing ailowed to stand for 5 minutes. The thyroxine
solution was given dropwise to the mixture over a period of 90—
120 minutes, keeping the pH between 6 and 6.5. The mixture was
then ailowed to stand overnight at 4 °C. The thyroxine did not all
remain in solution with l-ethyl-3-(3-dimethyl aminopropyl)car-
bodiimide hydrochloride s coupling reagent. The high molar ra-
tio of thyroxine was meant to compensate for possible precipita-
tion during the reaction, s it was known that it is almost impossi-
ble to keep thyroxine in aqueous solution at pH values lying on
the acid side of neutrality.
The purification of the conjugate was via an Ultrogel A6 column
(30 x 2.5 cm) using centrifugation step before the column run to
remove particulate material.
The Substitution rate was determined spectrophotometrically
using the molar lineic absorbance for thyroxine at 328 nm s
56 m2 · mol'1.
The Substitution rate with l-cyclohexyl-3-(2-morpholinyl-(4)-
ethyl)-carbodiimide methyl-p-toluene sulphonate was 16 thyrox-
ine per transferrin and for l-ethyl-3-(3-dimethyl aminopropyl)-
carbodiimide hydrochloride 24 thyroxine per transferrin.
Results
Bioluminescent conjugates
Figure 2 shows the effect of maleimide on acetate-
and adenylate- (or myo-) kinase, figure 3 on the
ATP-monitoring reagent.
Table 2 shows the binding of the four pyruvate ki-
nase-IgG conjugates made using the different hete-
robifunctional reagents
m-maleimidobenzoyl N-hydroxysuccinimide ester,
succinimidyl-4-()9-maleimidophenyl)-butyrate,
succinimidyl-4-(N-maleimidomethyl)-cyclohexane-
1-carboxylate and
succinimidyl-6-(/7-maleimidophenyl)-hexanoate,
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Fig. 2. The effect of maleimide on kinases in terms of concentra-
tion and time. The values on the Ordinate show the re^
sponse of the luminometer to ATP-production during the
incubation time. A flatter slope corresponds to a lower
rate of ATP-production, i. e. a higher degree of Inhibition
by maleimide.
a) adenylate kinase (myokinase)
b) acetate kinase, using an excess of acetyl phosphate to
drive the reaction in the direction of ATP-production.
Δ—Δ ηο maleimide
x—x 30 mmol/l maleimide
D—D 3 mmol/l maleimide
O—O 0.3 mmol/l maleimide
O—O 0.3 mmol/l maleimide, after 30 min
5
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u
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Fig. 3. The effect of maleimide on the ATP-monitoring System
(luciferin-luciferase) after injecting ATP (l · 10~6 mol/l -
50 μΐ).
Δ—Δ ηο maleimide
x—x 30 mmol/l maleimide
—D 3 mmol/l maleimide
Tab. 2. Binding of IgG-pyruvate kinase conjugates prepared by
using the heterobifunctional reagents shown in figure 1.
The B and B values are from a gentamicin SPALT as-
say (3) using polystyrene balls s a support for a genta-
micin-bovine serum albumin conjugate (see. Materials
and Methods section and I.e. (14)).
Dilution of the pyruvate Jdnase-l£G conjugate 1:40 in in-
cubation buffer. For unspecific binding ( B) bovine se-
rum albumin replaced the gentamicin-bovine serum albu-
min conjugate on the polystyrene balls (14).
All measurements made on the LKB 1250 l minometer.
Conjugate of donkey anti-rabbit
serum and pyruvate kinase with
m-Maleimidobenzoyl N^hydroxy- I
succinimide ester
SuccinimidyI^4-(N-maleimido- II
methyl)-cyclohexane- 1 -carboxylate
Sucxinimidyl-6-(p-maleimidp- III
phenyl)-hexanoate
Succinimidyl-4-(p^maleimido- IV
phenyl)-butyrate
B
(mV/s)
18.10
71.83
70.33
12.25
B
(mV/s)
0.64
0.47
0.60
0,46
The assay conditions were identical to those already published,
(3), replacing the microcrystalline cellulose by the antigen-coated
polystyrene ball and omitting the centrifugation Steps.
Results given s millivolt/second (mV/s) reflecting the rate of
ATP production.
to rabbit IgG coated polystyrene balls. All s bse-
quent tests were made with the donkey anti rabbit
IgG-succinimidyl-4^(N-maleimiclomethyI)-cyclo-
hexane-1-carboxylate-pyruvate kinase conjugate s
this performed best. Figure.^^shaws the Lineweaver*
Burk plots to test the effect on the enzyme kinetics
after coupling pyruvate kinase to IgG. Figure 4a is
for ADP, figure 4b for phosphoenolpyruvate.
The results show that the enzyme kinetics are influ^
enced by the coupling. The Michaelis-Menten con-
stants for ADP and phosphoenolpyruvate in the
antibody-pyruvate kinase conjugates s well s those
for unconjugated pyruvate kinase were calculated
from figure 4a and 4b. It can be seen that a vertical
line connecting the intersection of the antibody con-
jugate concentrations with the abscissa, goes through
the point where unconjugated pyruvate kinase inter>
sects the abscissa. By increasing the amount of
succinimidyl-4-(Nr-m leimidomethyl)^cyclohexane-
1-carboxylate to IgG, an increase in reaction rate
can be observed, however the maximal velocity
(Vmax) of unconjugated pyruvate kinase is never at-
tained.
The Km value at 23 0C observed for ADP was 1,74 x
ΙΟ"4 mol/l (lit. 3.0 x 10~4 at 30 0C (13)) and for
phosphoenolpyruvate 2.3 x IQ^4 mol/l (lit. 7.0 x
ΙΟ"5 mol/l at 30 PC (13)).
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Fig. 4. The Lineweaver-Burk plot used to determine the Km vaiue for conjugated pyruvate kinase, compared with the Km value for the
noneonjugated enzyme (x—x). The arrow on the abscissa represents the Km value.
a) /Cm-values for ADP
b) /Cm-values for phosphoenol pyruvate (PEP). Molar ratios enzyme: coupling reagent succinimidyl-4-(N-maleimidomethyl)-
cyclohexane-1 -carboxy late:
1:1.2 D—D 1:6 O—O 1:10 —
Chemiluminescent conjugates
Figure 5 shows the relative light intensity generated
by diazoluminol, diazoisoluminol and N-(4-amino-
butyl)-N-ethylisoluminol hemisuccinamide under
identical conditions. The detection limit of diazoiso-
luminol is around 3 decades higher than that for di-
azoluminol. The detection limit of (N-(4-aminobu-
tyl)-N-ethylisoluminol hemisuccinamide is sirhilar to
that for diazoluminol.
The results from the preparation of antibody conju-
gates using diazoluminol and diazoisoluminol agreed
in parts with other studies (10), however differ in
that in this läböratory mainly diazoluminol, and not
diazoisoluminol, conjugates have been found to be
mofe suitable. Diazoisoluminol gave no useable con-
jugates with antibodies ät the pH arid incubation
times tested here.
Figüre 6 shows the effect of testing the binding of the
column eluates of diazoluminol and diazoisoluminol
donkey-anti-rabbit IgG conjugates to räbbit IgG co-
ated polystyrene balls (= Bö or specific binding) and
to transferriii-coated balls äs protein-coated balls
not containing räbbit IgG (= ÜB or unspecific bind-
ing) under identical conditions namely: 2 elüate,
300 incubation buffer and a coated polystyrene
ball were incubated at ambient temperature for l h,
10000
t 1000
cn
CM
c
'(
<U
100
10
13x10 13x10'12
c(mol/tube]
13x10"
Fig. 5. The light Output obtained from different concentrations
of diazoluminol (·—·), diazoisoluminol (El—B) and
N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide
(A—A). The concentrations (mol/tube) of the test sub-
stances are shown on the abscissa. The values on the ordi-
nate represent the area under the light-emission curve in-
tegrated over 20 seconds.
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Fig. 6. Binding properties of diazoluminol-IgG and diazoisolu-
minol-IgG in fractions from an Ultrogel A4 column. 5 μΐ/
fraction were incubated with a rabbit IgG coated polysty-
rene ball (B , closed symbols) and a human transferrin co-
ated ball ( B, symbols open) to determine specific and
nspecific binding respectively.
Circles: diazoluminol-IgG
Squares: diazoisoluminol IgG
Tab. 3a. Comparison between the maximal (B ) and nspecific
binding ( B) of different diazoluminol IgG conjugates
represented by the fraction from the Ultrogel A4 co-
lumn eluate with maximal binding.
Ratio IgG to
diazoluminol
:8
:20
:40
:100
:200
B
(mV · s)
823
3310
13440
9840
9715
B
(mV · s)
52
66
220
465
975
Ratio
UB/BO
0.063
0.019
0.016
0.047
0.100
All measurements performed on an LKB 1251 Luminometer.
Assay conditions:
For B - rabbit IgG coated polystyrene balls
For B — human transferrin coated balls
10 μΐ column eluate, 300 μΐ incubation buffer and l coated poly-
styrene ball were incubated for 60 min at ambient temperature,
washed with l x l ml incubation buffer containing 0.5 ml/l Tween
20, followed by l x l ml 0.15 mol/1 NaCl.
Measuring conditions:
Transfer ball to measuring cuvette.
Light reaction initiated with 200 μΐ 0.8 mol/1 NaOH, 100 μΐ mi-
croperoxidase - MP 11 (5 μηιοΐ/ΐ), 120 μΐ Η2Ο2 (0.3 ml/l).
Integration time 20 seconds, results given s millivolt · seconds
(mV - s).
washed with l x l ml incubation buffer and l X l ml
0.15 mol/1 NaCl, then transferred to the luminome-
ter where the light emission was initiated.
As can be seen, the diazoisoluminol conjugate shows
a much lower specific binding than the diazoluminol
conjugate, showing that isoluminol derivatives could
not be used in that way in any assay Systems.
At pH 4 diazoluminol gave no useful conjugates.
When using diazoluminol a reaction time of 24 h at
4 °C gave optimal results. Shorter incubation times
gave a lower Substitution rate, whereas incubation
times longer than 24 h did not give rise to better con-
jugates.
Table 3a shows the effect of the Substitution ratio of
diazoluminol: donkey anti rabbit IgG, the optimal
Substitution rate being around 40: l s far s the sig-
nal to noise ratio (B0/UB) was concerned.
Figure 7 shows the effect of the molar ratio diazolu-
minol: IgG on the binding characteristics of the Ul-
trogel A4 column fractions. 10 μΐ per fraction were
tested analogically to the conditions described above
for figure 6.
It can be seen that a higher Substitution rate only led
to a dramatic increase in the nspecific binding s
can be seen in the 1:100 curve.
Table 3b shows the comparison between maximal
(B ) and nspecific binding ( B) for different N-(4-
aminobutyl)-N-ethylisoluminol hemisuccinamide
active ester donkey anti rabbit IgG conjugates using
different Substitution ratios.
A Substitution ratio of about 60: l· gave the best re-
sults, a higher Substitution of 120:1 giving a higher
noise to signal ratio (UB/B0). Lower Substitution ra-
tios gave a lower light intensity but no difference in
the ratio UB/B0.
Tab. 3b. Comparison between the maximal (B ) and nspecific
binding ( B) of different (N-(4-aminobutyl)-N-ethyl-
isoluminol hemisuccinamide) active ester donkey anti-
rabbit IgG conjugates using the fraction from the Ul-
trogel A4 column with maximal binding.
Ratio IgG to
N-(4-amino-
butyl)-N-ethyl-
isoluminol hemi-
succinamide
active ester
1: 30
1: 60
1:120
B
(mV- s)
6085
21662
33442
B
(mV · s)
192
686
1706
Ratio
UB/BO
0.031
0.032
0.051
Assay'conditions:
5 μΐ of a 1:10 dilution (in elution buffer) of the fraction with max-
imal binding were used analogically to, {he assay conditions de-
scribed in table 3a.
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Fig. 7. Effect of different Substitution rates diazoluminol: IgG on
binding profile of column eluent. The labelled antibody
was äs in figure 6, i.e. an anti rabbit IgG, the coated bails
for specific (Bö) and unspectfic binding (ÜB) again being
rabbit-IgG and human transferrin äs above. The incuba-
tion time was 60 min, 5 of the column fraction being
tested. The ÜB represents the non-specific adsorption to
or reaction with the transferrin coated polystyrene ball.
Ratio
IgG: diazoluminol
Bö O—O 1:100 O—O ÜB
Bö — 1: 40 — ÜB
Bö — 1: 20
Bö — 1: 8
Discession
The pfoblems and possible Solutions for set up solid
phase based luminescence immunoassays have been
limited to the preparation of luminescence conju-
gates and hapteii-pfotein conjugates in the second
paft of this trilogy.
The bioluminescent labels here described show the
problems of working with kinases, that is the cou-
pling of kinases to antigens or antibodies without
loss of antigenic or enzymatic actjvity. Of all kinases
tested only pyruvate kinase was robust enough to
"survive" coupling using the heterobifunctional rea-
gents tested here. The other kinases, although at-
traetive on paper, for example adenylate kinase with
its molecular weight of 21000, resistanee to acid pH,
high turnover rate and single Substrate (ADP) were
unable to be used due to their sensitivity to maleim-
ide. Other coupling reagents (carbodiimides, pen-
tane-l,5-dial, bisfcpoxirane) were found to be un-
suitable äs the enzyme activity disappeared during
coupling. The results show that pyruvate kinase, des-
pite its high molecular weight (240000) was used be-
eause of available SH-groups not present in the ac-
tive centre.
Whether the use of SH-group introducing reagents
such äs (N-succinimidyl 3-(2-pyridyldithio) propion-
ate) could make the other kinases useable, is a point
worth considering.
The results from the Lineweaver-Burk plots con-
firmed that the coupling reagents here chosen led to
changes in enzyme activity and structure, äs mea-
sured by Substrate affinity. As previously stated (1),
difficulties of finding a suitable antimicrobial reagent
for bioluminescent labels of this type presents a ma-
jor drawback, which suggests that such labels should
only be used where insufficient sensitivity can be ob-
tained with chemiluminescent labels. The latter do
not suffer such problems, partly due to their hydra-
zide structure in the case of diazoluminol, which in
itself appears to exert bacteriostatic properties.
Many of the chemiluminescent labels described in
the literatüre suffer from the drawback that their
synthesis is somewhat complicated (6). The labels
described here are simple to produce, and do not re-
quire much expertise and equipment, äs well äs giv-
ing out sufficient light for most purposes, althoügh
N-(4-aminobutyl)-N-ethylisoluminol hemisuccin-
amide gave the best results.
Diazoluminol conjugates have in contrast to diazo-
isoluminol conjugates a higher light Output (10). The
reaction of diazoisoluminol in the presence of pro-
teins was far quicker than of diazoluminol, äs moni-
tored by the decolorisation. This may be explained
by the active diazogroup, which in isoluminol is lo-
cated on the less sterically hindered 6 (4)-position.
Diazoluminol is not äs reactive due to the position of
the oxo-group on the azine ring, and due to its ability
to build ä stable internal structure (see fig. 8). The
reaction of proteins with diazoluminol could be di-
vided into two distinct phases, a rapid reaction with
the protein in alkaline solution (pH 9—10) in which
the reaction mixture remained red (excited electrons
in the diazo bridge are still present). Such conjugates
are stable enough to be separated on an agarose gel
column (Ultrogel A4 or A6), however they are un-
stable enough to transfer the diazoluminol group to
another protein if the latter is present in excess. At
this stage a transitional bonding is present in which
both ionic and covalent components are present. The
second stage of the reaction is slower and is associat-
ed with a disappearence of the red coloration, and
the appearance of a yellow-orange colour, in which
the covalent bonding is stable. These conjugates can
be stored at —20 °C for over a year without appreci-
able loss in immunological and luminogenic activity.
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^ Internal stobilisation
(preferred)
Oimer formation
(not preferred)
Formation of diazotate under alkaline conditions
Structure of diazoisoluminol
(dimer formation preferred)
Fig. 8. This set of reactions shows the possible reactions occur-
ring during diazotisation under alkaline conditions, äs car-
ried out here. Diazoluminol prefers an internal stabilisa-
tion (above reaction sequence - centre picture) whereas
diazoisoluminol prefers dimer formation äs the position of
the diazogroup is unfavorable for an internal stabilisation.
This may account for the fact that diazoisoluminol is
formed in solution, but precipitates out within 30 minutes
äs a golden-yellow crystalline deposit. Diazoluminol at
equimolar concentrations remains in solution. The middle
set of reactions shows the formation of diazotate under
alkaline conditions.
An important point to mention here, is that the
materials to be diazotised must be free from azide, äs
diazoluminol reacts with sodium azide to form com-
pounds which do not react with the tyrosine moieties
of the protein. Here the decolorisation of the reac-
tion mixture takes place within seconds, a yellöw so-
lution being formed. If this solution is then adjusted
to pH 7 with phosphate buffer, it darkens due to
reaction with atmospheric oxygen, suggesting that
poly^phenol derivatives may be formed. This would
be in accordance with a free radical reactiqn follow-
ing the loss of nitrogen from the diazoluminol-azide
complex. These unwanted effects can be avoided by
treatment öf the material to be diazotised with
DEAE cellulose in the form of a short column (2,
15), äs already described.
The comparison of the detection limits for diazolu-
minol and N-(4-aminobutyl)-N-ethylisoluminol he-
misuccinämide shows no significaiit difference. On
the other hand N-(4-aminobutyl)-N-ethyüsplüminol
hemisuccinamide active ester labelled IgG-mole-
cules show much better light intensities than those
labelled with diazoluminol. This could be explained
by the different reaction mechanism of these two
compounds. The reaction of diazoluminol with ty-
rosyl-residues of IgG is of an oxidative nature and
may destroy antibödy stracture (compare chloram-
ine-T iodination of certain proteins which lead to ac-
tivity loss). The N-(4-aminobutyl)-N-ethylisolumin-
ol hemisuccinamide active ester reacts with amino-
moieties under non-oxidative conditions (compare
Bolton-Hunter iodination of proteins).
Finally, it can be stated that the choice of label used,
i.e., whether chemi- or bioluminescent depends to a
large extent upon the sensitivity of the assay, and al-
though the assays described to date mäinly use the
former (7, 8, 9), the latter may have to be used until
sufficient sensitivity can be achieved using chemi-
luminescent markers.
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